After those 2 weeks, the algorithm’s ability might have limitations due to its design, safety parameters to prevent hypoglycemia, system constraints (sensor accuracy, insulin absorption variability and speed of insulin action) and meal-related challenges (initial improvement might reflect better basal control, while meal-related changes in glycemia could remain a challenge). The gene discussed is INS; the disease is Hypoglycemia.